Corstrate is a privately held boutique consultancy operating exclusively within the life sciences sector, providing outsourced and fractional business development services to CROs, CDMOs, biotechs, and other life sciences service companies seeking to build structured, predictable commercial pipelines in the United States and United Kingdom. The company is a small, agile operation that positions itself as an embedded extension of the client’s commercial team rather than a traditional agency, with named clients including RiverArk, Gabather, ClinActics, and RareCan.

The company reports having sourced over USD 27.6 million in qualified pipeline for life sciences clients across its engagements, providing a tangible commercial track record. Strategic partners include Lemlist (email outreach and sales automation platform) and Bioalliance Strategies. Corstrate publishes practical business development guidance through its blog, covering topics including fractional BD models, pipeline optimisation, prospecting best practices, and CRO versus CDMO market dynamics — positioning itself as a thought leader within its target market.

Key Products and Services

Fractional Business Development

• Outsourced senior business development leadership for CROs, CDMOs, and life sciences service providers that require structured BD strategy and execution without the cost or commitment of a full-time hire
• Strategy design, outreach execution, pipeline management, and commercial performance oversight delivered as an embedded fractional resource

Lead Generation

• Targeted outbound prospecting and structured follow-up programmes designed to generate qualified opportunities for life sciences service companies
• Outreach campaign design, prospect list building, multi-channel outbound execution, and conversion tracking

Commercial Strategy

• Positioning, messaging, and targeting advisory to improve visibility and accelerate revenue growth for life sciences service organisations
• Client acquisition strategy and international expansion planning, particularly for companies entering or growing in the US and UK markets

Fractional CCO and Advisory

• Senior commercial leadership on a fractional basis — Chief Commercial Officer-level strategic input without a full-time executive hire
• Advisory on portfolio development, client retention, pricing strategy, and commercial team structure

Life Sciences Conference and Event Support

• Business development support around life sciences conferences and events, including pre-event outreach, meeting scheduling, and post-event follow-up to maximise commercial return from conference attendance

Corstrate occupies a focused niche in the commercial services market for life sciences outsourcing companies — specifically CROs and CDMOs — that have scientific and operational capability but lack the dedicated business development infrastructure to generate a consistent, qualified commercial pipeline in competitive markets such as the US and UK. For smaller CROs and CDMOs in particular, the cost of a full-time senior BD hire is often disproportionate to the immediate revenue opportunity, making a fractional, outsourced model an economically rational alternative. Corstrate’s life sciences sector specificity — rather than offering generic B2B sales outsourcing — means its team understands the buyer landscape, decision-making timelines, and competitive positioning considerations specific to pharmaceutical outsourcing procurement. The USD 27.6 million in stated qualified pipeline generated provides a commercially tangible credential.